(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ILYA PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ILYA PHARMA

ST13

US500000079247429

Class

5, 42

Filing

79247429

Registration

5790985

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

02/10/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

09/19/2018

Registration date

07/02/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/16/2026

Last transaction

02/10/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

09

Owner location

SE

Examiner

BIBB, SCOTT

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the following: the stylized wording "ILYA PHARMA" in black, with a light blue shaded square to the right of "PHARMA", all on a white background.

Holders and representatives

Holders

Ilya Pharma AB

Representatives

Donna J. Bunton NIXON & VANDERHYE P.C.

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; pharmaceutical and veterinary preparations for treatment of wound and wound healing in skin and mucosa; pharmaceutical and veterinary preparations for the treatment of diseases and conditions in the areas of oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmologyexcluding preparations for the treatment of constipation and/or preparations including psyllium

Class 42

Research and development in the fields of biologicalpharmacologicalveterinarymicrobiologicalbiomedicalpharmabioticsbiotherapeutical and biotechnological areas

Publications

History of USPTO decisions and trademark events.

26 publications found

C71T

CANCELLED SECTION 71

01/16/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/02/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/11/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/08/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/19/2019

FIMP

FINAL DISPOSITION PROCESSED

10/19/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/02/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

07/02/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/16/2019

PUBO

PUBLISHED FOR OPPOSITION

04/16/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/27/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/01/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/28/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/28/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/28/2019

RFNT

REFUSAL PROCESSED BY IB

02/16/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/08/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/08/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/25/2019

RFRR

REFUSAL PROCESSED BY MPU

01/24/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/11/2019

CNRT

NON-FINAL ACTION WRITTEN

01/10/2019

DOCK

ASSIGNED TO EXAMINER

12/30/2018

MAFR

APPLICATION FILING RECEIPT MAILED

12/21/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/17/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/13/2018

Continuous trademark protection

Get notified about every new filing that threatens ILYA PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.